Barbara Beck
Known title: DirectorCIK: 0001184925
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
RBC and Citi highlight Ecolab's pricing power and specialty chemical strength. Recent analyst notes from RBC Capital Markets and Citi have focused on Ecolab's ability to maintain pricing and organic growth. These firms view the company as a defensive option that may benefit from a weaker dollar. The positive sentiment aligns with the stock trading near its 52-week high, reflecting strong investor interest in its stable earnings profile.
Transaction History
| PFGC | ▲ Buy | Grant | 3,516 | $0 | 11/19/2025 | View on chart |
| PFGC | ▲ Buy | Grant | 3,682 | $0 | 11/19/2024 | View on chart |
| ECL | ▲ Buy | Grant | 146 | $0 | 3/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 157 | $36K | 3/31/2024 | View on chart |
| ECL | ▲ Buy | Grant | 157 | $0 | 12/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 176 | $35K | 12/31/2023 | View on chart |
| PFGC | ▲ Buy | Grant | 2,768 | $0 | 11/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 206 | $35K | 9/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 184 | $0 | 9/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 168 | $0 | 6/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 188 | $35K | 6/30/2023 | View on chart |
| ECL | ▲ Buy | Grant | 190 | $0 | 3/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 212 | $35K | 3/31/2023 | View on chart |
| ECL | ▲ Buy | Grant | 215 | $0 | 12/31/2022 | View on chart |
| ECL | ▲ Buy | Grant | 240 | $35K | 12/31/2022 | View on chart |
| PFGC | ▲ Buy | Grant | 2,727 | $0 | 11/16/2022 | View on chart |
| ECL | ▲ Buy | Grant | 214 | $0 | 9/30/2022 | View on chart |
| ECL | ▲ Buy | Grant | 240 | $35K | 9/30/2022 | View on chart |
| ECL | ▲ Buy | Grant | 205 | $0 | 6/30/2022 | View on chart |
| ECL | ▲ Buy | Grant | 230 | $35K | 6/30/2022 | View on chart |
| ECL | ▲ Buy | Grant | 175 | $0 | 3/31/2022 | View on chart |
| ECL | ▲ Buy | Grant | 196 | $35K | 3/31/2022 | View on chart |
| ECL | ▲ Buy | Grant | 133 | $31K | 12/31/2021 | View on chart |
| ECL | ▲ Buy | Grant | 123 | $0 | 12/31/2021 | View on chart |
| PFGC | ▲ Buy | Grant | 3,618 | $0 | 11/18/2021 | View on chart |
| ECL | ▲ Buy | Grant | 136 | $0 | 9/30/2021 | View on chart |
| ECL | ▲ Buy | Grant | 148 | $31K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
PFGC sees mixed analyst views and new institutional interest
Performance Food Group is drawing attention from new and existing investors. Billionaire Dan Loeb’s Third Point bought stakes in the company, while Morgan Stanley raised its price target to $136. Conversely, TD Cowen lowered its target to $110. The stock is currently trading near its 52-week high, reflecting a period of strong price movement.
PFGC sees mixed analyst views and new institutional interest. Performance Food Group is drawing attention from new and existing investors. Billionaire Dan Loeb’s Third Point bought stakes in the company, while Morgan Stanley raised its price target to $136. Conversely, TD Cowen lowered its target to $110. The stock is currently trading near its 52-week high, reflecting a period of strong price movement.